Skip to main content
. 2013 Apr 19;121(6):711–716. doi: 10.1289/ehp.1205918

Table 2.

Blood lead concentration in relation to walking speed.

Quintile range (μg/dL) Total [n (%)] Model 1 Model 2 Model 3 Model 4
Mean change in walking speed (ft/sec) (95% CI) p-Value Mean change in walking speed (ft/sec) (95% CI) p-Value Mean change in walking speed (ft/sec) (95% CI) p-Value Mean change in walking speed (ft/sec) (95% CI) p-Value
Women
0.2 to ≤ 1.2 413 (23.0) 0 (reference) 0 (reference) 0 (reference) 0 (reference)
1.3 to ≤ 1.6 348 (19.4) –0.024 (–0.115, 0.066) 0.59 –0.021 (–0.113, 0.072) 0.65 –0.026 (–0.116, 0.063) 0.55 –0.024 (–0.112, 0.064) 0.58
1.7 to ≤ 2.1 341 (19.0) –0.022 (–0.123, 0.080) 0.67 –0.018 (–0.108, 0.071) 0.68 –0.028 (–0.132, 0.077) 0.59 –0.027 (–0.118, 0.063) 0.54
2.2 to ≤ 2.9 356 (19.8) –0.067 (–0.158, 0.024) 0.14 –0.097 (–0.184, 0.009) 0.03 –0.075 (–0.165, 0.015) 0.10 –0.104 (–0.187, –0.021) 0.02
3.0 to ≤ 53.0 340 (18.9) –0.112 (–0.795, –0.029) 0.01 –0.117 (–0.191, 0.043) 0.01 –0.101 (–0.187, –0.015) 0.02 –0.114 (–0.191, –0.038) 0.01
Trend 1,798 0.006 0.002 0.015 0.005
Men
0.2 to ≤ 1.7 399 (22.2) 0 (reference) 0 (reference) 0 (reference)
1.8 to ≤ 2.3 364 (20.3) 0.056 (–0.043, 0.156) 0.25 0.061 (–0.047, 0.172) 0.27 0.036 (–0.062, 0.135) 0.46 0.057 (–0.050, 0.165) 0.29
2.4 to ≤ 3.0 342 (19.1) 0.054 (–0.039, 0.146) 0.24 0.020 (–0.075, 0.116) 0.67 0.042 (–0.051, 0.134) 0.36 0.017 (–0.073, 0.107) 0.71
3.1 to ≤ 4.3 354 (19.7) 0.053 (–0.035, 0.142) 0.23 0.065 (–0.032, 0.162) 0.18 0.057 (–0.036, 0.150) 0.22 0.082 (–0.012, 0.175) 0.08
4.4 to ≤ 54.0 336 (18.7) –0.077 (–0.177, 0.024) 0.13 –0.047 (–0.162, 0.073) 0.43 –0.066 (–0.173, 0.041) 0.22 –0.029 (–0.154, 0.097) 0.64
Trend 1,795 0.03 0.34 0.10 0.60
Model 1: adjusted for demographic (age, education, ethnicity) and anthropometric variables (height and waist circumference). Model 2: model 1 covariates plus lifestyle variables (alcohol, smoking, physical activity). Model 3: model 1 covariates plus medical comorbidities and biomarkers (arthritis, diabetes, heart condition, hypertension, homocysteine, and C-reactive protein). Model 4: fully adjusted model.